Flora Pirozzi

1.4k total citations
28 papers, 810 citations indexed

About

Flora Pirozzi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Flora Pirozzi has authored 28 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Flora Pirozzi's work include Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cardiovascular Function and Risk Factors (6 papers) and Heart Failure Treatment and Management (4 papers). Flora Pirozzi is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (10 papers), Cardiovascular Function and Risk Factors (6 papers) and Heart Failure Treatment and Management (4 papers). Flora Pirozzi collaborates with scholars based in Italy, China and United States. Flora Pirozzi's co-authors include Carlo G. Tocchetti, Domenico Bonaduce, Pasquale Abete, Alessandra Ghigo, Valentina Mercurio, Paolo Parrella, Mario Petretta, Gianluca Testa, Francesco Curcio and Ilaria Liguori and has published in prestigious journals such as The Journal of Physiology, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Flora Pirozzi

28 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flora Pirozzi Italy 16 372 206 162 145 127 28 810
Patrizia Fabbi Italy 15 461 1.2× 268 1.3× 140 0.9× 212 1.5× 93 0.7× 26 1.0k
Panagiotis Vasileiou Greece 15 243 0.7× 265 1.3× 213 1.3× 53 0.4× 101 0.8× 31 902
Akihiro Hirashiki Japan 19 594 1.6× 229 1.1× 155 1.0× 111 0.8× 197 1.6× 75 1.1k
Cheng‐Huang Su Taiwan 14 449 1.2× 227 1.1× 146 0.9× 44 0.3× 187 1.5× 71 942
Wilson Tong United States 11 586 1.6× 161 0.8× 187 1.2× 93 0.6× 172 1.4× 15 1.1k
Nadezhda Glezeva Ireland 14 497 1.3× 313 1.5× 57 0.4× 81 0.6× 100 0.8× 23 901
Akira Funayama Japan 15 382 1.0× 149 0.7× 247 1.5× 40 0.3× 134 1.1× 25 807
Ningfu Wang China 17 243 0.7× 276 1.3× 80 0.5× 49 0.3× 121 1.0× 47 844
Tomoko Ichiki United States 22 779 2.1× 261 1.3× 96 0.6× 130 0.9× 144 1.1× 69 1.2k

Countries citing papers authored by Flora Pirozzi

Since Specialization
Citations

This map shows the geographic impact of Flora Pirozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flora Pirozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flora Pirozzi more than expected).

Fields of papers citing papers by Flora Pirozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flora Pirozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flora Pirozzi. The network helps show where Flora Pirozzi may publish in the future.

Co-authorship network of co-authors of Flora Pirozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Flora Pirozzi. A scholar is included among the top collaborators of Flora Pirozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flora Pirozzi. Flora Pirozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pirozzi, Flora, Remo Poto, Luisa Aran, et al.. (2021). Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors. Current Oncology Reports. 23(2). 46 indexed citations
2.
Pirozzi, Flora, Remo Poto, Alessandra Cuomo, et al.. (2021). Oxidative stress in anticancer therapies-related cardiac dysfunction. Free Radical Biology and Medicine. 169. 410–415. 4 indexed citations
3.
Poto, Remo, Giancarlo Marone, Flora Pirozzi, et al.. (2021). How can we manage the cardiac toxicity of immune checkpoint inhibitors?. Expert Opinion on Drug Safety. 20(6). 685–694. 10 indexed citations
4.
Cuomo, Alessandra, Giovanni D’Angelo, Francesco Fiore, et al.. (2021). New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management. Current Heart Failure Reports. 18(4). 191–199. 8 indexed citations
5.
Testa, Gianluca, Michele Russo, Silvia Parisi, et al.. (2020). Bmi1 inhibitor PTC-209 promotes Chemically-induced Direct Cardiac Reprogramming of cardiac fibroblasts into cardiomyocytes. Scientific Reports. 10(1). 7129–7129. 31 indexed citations
6.
Cuomo, Alessandra, Flora Pirozzi, Stefania Loffredo, et al.. (2020). Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment. International Journal of Molecular Sciences. 21(12). 4430–4430. 20 indexed citations
7.
Cuomo, Alessandra, Flora Pirozzi, Michele Russo, et al.. (2020). Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications. Current Oncology Reports. 23(1). 7–7. 15 indexed citations
8.
Cacciatore, Francesco, Cristiano Amarelli, Ciro Maiello, et al.. (2020). Sacubitril/Valsartan in Patients Listed for Heart Transplantation: Effect on Physical Frailty. ESC Heart Failure. 7(2). 757–762. 23 indexed citations
9.
Mercurio, Valentina, Alessandra Cuomo, Roberta Della Pepa, et al.. (2019). What Is the Cardiac Impact of Chemotherapy and Subsequent Radiotherapy in Lymphoma Patients?. Antioxidants and Redox Signaling. 31(15). 1166–1174. 17 indexed citations
10.
Li, Mingchuan, Michele Russo, Flora Pirozzi, Carlo G. Tocchetti, & Alessandra Ghigo. (2019). Autophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(3). 118493–118493. 32 indexed citations
11.
Varricchi, Gilda, Pietro Ameri, Christian Cadeddu Dessalvi, et al.. (2018). Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective. Frontiers in Physiology. 9. 167–167. 121 indexed citations
12.
Sala, Valentina, Maria Chiara De Santis, James J. Cimino, et al.. (2018). PI3Kγ inhibition protects from anthracycline-induced heart failure and reduces tumor growth. Vascular Pharmacology. 103-105. 60–60. 1 indexed citations
13.
Liguori, Ilaria, Luisa Aran, Giulia Bulli, et al.. (2017). Statins in cardiovascular prevention in the oldest-old. A black hole. 65(4). 263–270. 4 indexed citations
14.
Passaro, Fabiana, Gianluca Testa, Ciro Costagliola, et al.. (2017). Nanotechnology-Based Cardiac Targeting and Direct Cardiac Reprogramming: The Betrothed. Stem Cells International. 2017. 1–12. 18 indexed citations
15.
Curcio, Francesco, Claudia Basile, Ilaria Liguori, et al.. (2016). Biomarkers in sarcopenia: A multifactorial approach. Experimental Gerontology. 85. 1–8. 156 indexed citations
16.
17.
Mercurio, Valentina, Flora Pirozzi, Edoardo Lazzarini, et al.. (2016). Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs. Journal of Cardiac Failure. 22(6). 449–458. 61 indexed citations
18.
Petretta, Mario, et al.. (2011). Review and Metaanalysis of the Frequency of Familial Dilated Cardiomyopathy. The American Journal of Cardiology. 108(8). 1171–1176. 77 indexed citations
19.
Tarantini, Luigi, et al.. (2010). [Prevention of heart failure].. PubMed. 11(5 Suppl 3). 81S–86S. 2 indexed citations
20.
Caselli, Antonella, et al.. (2005). Transcutaneous oxygen tension msonitoring after successful revascularization in diabetic patients with ischaemic foot ulcers. Diabetic Medicine. 22(4). 460–465. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizia Fabbi Breakdown of academic impact, for papers by Panagiotis Vasileiou Breakdown of academic impact, for papers by Akihiro Hirashiki Breakdown of academic impact, for papers by Cheng‐Huang Su Breakdown of academic impact, for papers by Wilson Tong Breakdown of academic impact, for papers by Nadezhda Glezeva Breakdown of academic impact, for papers by Akira Funayama Breakdown of academic impact, for papers by Ningfu Wang Breakdown of academic impact, for papers by Tomoko Ichiki
Rankless by CCL
2026